title: Libman-Sacks endocarditis and severe aortic regurgitation in a patient with systemic lupus erythematosus in peritoneal dialysis.
authors.forename: Y
authors.initials: Y
authors.lastname: Barreiro Delgado
authors.forename: I
authors.initials: I
authors.lastname: García Méndez
authors.forename: N
authors.initials: N
authors.lastname: Martín Alemany
authors.forename: J
authors.initials: J
authors.lastname: Calabia Martínez
authors.forename: M
authors.initials: M
authors.lastname: Morales Fornos
authors.forename: M
authors.initials: M
authors.lastname: Fuertes
authors.forename: M
authors.initials: M
authors.lastname: Vallès Prats
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000150:complications* / Q000601:surgery; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004696:Endocarditis / Q000209:etiology* / Q000601:surgery; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008181:Lupus Nephritis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D008875:Middle Aged; D010490:Pericardial Effusion / Q000209:etiology; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology; D006435:Renal Dialysis
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents